Innovation Pharmaceuticals Inc (IPIX)

[BooDog]

Achieving CTIX Potential Catalysts and Past Milestones

From Sox's post/ updated

Q2 2016 Potential Catalysts

- P top-line data (Phase 2) EXCEEDED Endpoints
http://cellceutix.com/cellceutix-phase-2-trial-of-prurisol-for-mild-to-moderate-psoriasis-meets-primary-endpoint/#sthash.GZ5nN9nA.dpbs

- B-OM interim data (Phase 2)
- K top-line data (Phase 1)
- Start of B-ABSSSI (Phase 3)
- Start of B-UP (Phase 2, proof of concept)
- Start of K-ovarian (Phase 2)
- Fast track designation for B-ABSSSI
- ASM Microbe presentations (June 19-20)

Past Milestones

- QIDP designation for B-ABSSSI
- Fast track designation for B-OM
- Orphan drug designation for K-ovarian cancer
- Orphan drug designation for K-pancreatic cancer
- Orphan drug designation for K-retinoblastoma
- Rare pediatric disease designation for K-retinoblastoma
- B-ABSSSI positive Phase 2b top-line & bottom line data
- Completion of cohort 11 (750 mg/m2)
- K positive primary outcome (Phase 1)
- P positive primary outcome (Phase 1)
- Stable formulation of B at room temperature
- MTA extension on testing B in implanted devices

Clinical Trials

1. P (Phase 1, completed): https://clinicaltrials.gov/ct2/show/NCT02494479?term=cellceutix&rank=1
2. P (Phase 2, not recruiting): COMPLETED https://clinicaltrials.gov/ct2/show/NCT02101216?term=cellceutix&rank=2

https://clinicaltrials.gov/ct2/show/results/NCT02494479?term=Prurisol&rank=2 Results pending to be posted.

3. B-OM (Phase 2, recruiting): https://clinicaltrials.gov/ct2/show/NCT02324335?term=cellceutix&rank=3
4. B-ABSSSI (Phase 2, completed): https://clinicaltrials.gov/ct2/show/NCT02052388?term=cellceutix&rank=4
5. K (Phase 1, completed): https://clinicaltrials.gov/ct2/show/NCT01664000?term=cellceutix&rank=5

Abbreviations

K – Kevetrin
B – Brilacidin
P – Prurisol
ABSSSI – acute bacterial skin and skin structure infections
OM – oral mucositis
UP – ulcerative proctitis
QIDP – qualified infectious disease product

Excellent news today pushing the pipeline and solidifying Cellceutix's potential to grow even further to catch the eyes of big pharma. We see the attempts of some to hold this down. To an extent it's expected to see some selling on news. IMO, as we see the volume pick up we'll see the price pick up.

And,,,,

BeingReal Tuesday, 05/24/16 11:14:06 AM
Re: BooDog post# 148662
Post # of 148673

Thanks BD for the summary, but one missing catalysts is the court decision. Does anyone have an idea on the timeline for a decision regarding the dismissal filing?